Research Streams
01 — Metabolic Research
GLP-1, GIP, and glucagon receptor agonists for metabolic pathway investigation
Metabolic research peptides target the incretin hormone pathways — a family of gut-derived signalling molecules that regulate glucose-dependent insulin secretion, appetite signalling, and energy expenditure. Several compounds in this class have advanced to late-stage clinical trials, generating substantial interest in the mechanistic underpinnings of their multi-receptor engagement. The following catalogue comprises peptides selected for their relevance to contemporary metabolic pathway investigation.
Metabolic Research
Retatrutide
From $99 AUD In Stock
A synthetic triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials for metabolic pathway research. The first of its class to engage all three incretin receptor systems.
Metabolic Research
MOTS-c
From $75 AUD In Stock
A mitochondrial-derived peptide encoded in the mitochondrial genome. Studied for its role in metabolic regulation and cellular energy homeostasis in preclinical models.
Metabolic Research
Kisspeptin
$70 AUD In Stock
A neuropeptide that acts as a potent stimulator of gonadotropin-releasing hormone (GnRH). Investigated for its role in reproductive axis signalling and metabolic-endocrine crosstalk.
For detailed research data and mechanism analysis, visit our blog (coming soon).
All products are research compounds intended for laboratory research use only. Not for human or veterinary use. Kinetic Labs does not provide dosing guidance, therapeutic recommendations, or medical advice of any kind.